TradingView
JetEquities
Jun 3, 2019 4:55 PM
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at App
Long
NYSE:EBS
30
Emergent Biosolutions, Inc.
NYSE
Description
⋅
Jun 3, 2019 4:55 PM
EBS: Emergent BioSolutions
2019-06-03 06:30:00
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness - GlobeNewswire
Beyond Technical Analysis
More